A feasibility randomised controlled trial of short-term fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer: SWiFT protocol

A feasibility randomised controlled trial of short-term fasting prior to CAPOX chemotherapy for stage 2/3 colorectal cancer: SWiFT protocol

Abstract Background Capecitabine and oxaliplatin (CAPOX) chemotherapy is a standard treatment for stage 2/3 colorectal cancer. Treatment is associated with dose-limiting toxicities such as neutropenia, vomiting, diarrhoea, and stomatitis. Short-term fasting prior to chemotherapy may help protect nor...

Full description

Bibliographic Details
Main Authors: Ellie Shingler, Claire Perks, Georgia Herbert, Andy Ness, Charlotte Atkinson
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Pilot and Feasibility Studies
Subjects:
Short-term fast
Dietary restriction
Colorectal cancer
Feasibility
RCT
Online Access:http://link.springer.com/article/10.1186/s40814-019-0505-7

Internet

http://link.springer.com/article/10.1186/s40814-019-0505-7

Similar Items